Ming-Ching Lee

ORCID: 0000-0002-7984-848X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Treatments and Mutations
  • Cancer Research and Treatments
  • Molecular Sensors and Ion Detection
  • Lung Cancer Diagnosis and Treatment
  • Melanoma and MAPK Pathways
  • Microtubule and mitosis dynamics
  • RNA modifications and cancer
  • Cancer Cells and Metastasis
  • Cell death mechanisms and regulation
  • Mechanisms of cancer metastasis
  • Radiomics and Machine Learning in Medical Imaging
  • Analytical Chemistry and Sensors
  • Luminescence and Fluorescent Materials
  • Sulfur Compounds in Biology
  • Lung Cancer Research Studies
  • Congenital Diaphragmatic Hernia Studies
  • Myasthenia Gravis and Thymoma
  • Esophageal and GI Pathology
  • Hepatitis B Virus Studies
  • Nanowire Synthesis and Applications
  • Electrochemical sensors and biosensors
  • Medical Imaging and Pathology Studies
  • Congenital Anomalies and Fetal Surgery
  • PI3K/AKT/mTOR signaling in cancer
  • Advanced biosensing and bioanalysis techniques

Taichung Veterans General Hospital
2016-2025

National Health Research Institutes
2010-2023

National Chung Cheng University
2022

National Yang Ming Chiao Tung University
2014-2019

National Yang Ming University Hospital
2014-2019

Taiwan Shoufu University
2010-2019

Memorial Sloan Kettering Cancer Center
2014-2017

Shinshu University
2016

Institute of Clinical Research
2014-2015

Cornell University
2015

To examine the significance of proposed International Association for Study Lung Cancer, American Thoracic Society, and European Respiratory Society (IASLC/ATS/ERS) histologic subtypes lung adenocarcinoma patterns recurrence and, among patients who recur following resection stage I adenocarcinoma, postrecurrence survival (PRS).We reviewed with had undergone complete surgical from 1999 to 2009 (N = 1,120). Tumors were subtyped by using IASLC/ATS/ERS classification. The effects dominant...

10.1200/jco.2015.60.9818 article EN Journal of Clinical Oncology 2015-08-11

Purpose To perform competing risks analysis and determine short- long-term cancer- noncancer-specific mortality morbidity in patients who had undergone resection for stage I non-small-cell lung cancer (NSCLC). Patients Methods Of 5,371 consecutive curative-intent of primary at our institution (2000 to 2011), 2,186 with pathologic NSCLC were included the analysis. All preoperative clinical variables known affect outcomes analysis, specifically, Charlson comorbidity index, predicted...

10.1200/jco.2016.69.0834 article EN Journal of Clinical Oncology 2016-10-11

Nrf2 is a key transcription factor for genes coding antioxidants, detoxification enzymes, and multiple drug resistance it also confers to anticancer drugs. Here, we hypothesized that mutant p53 could upregulate expression at the transcriptional level, thereby conferring cisplatin in non-small cell lung cancer (NSCLC). Luciferase reporter assays real-time PCR analysis indicated promoter activity its mRNA levels were markedly suppressed by wild-type p53, but not p53. Chromatin...

10.18632/oncotarget.6150 article EN Oncotarget 2015-10-19

Inhibitors of antiapoptosis protein (IAP) have been implicated in the resistance to cisplatin. Therefore, verifying which pathway is involved cIAP2 upregulation may be helpful finding a feasible inhibitor increase chemotherapeutic efficacy human papillomavirus (HPV)-infected lung cancer.Specific inhibitors different pathways were used verify transcription. promoter fragments with various deletions and/or mutations constructed by site-directed mutagenesis. cIAP2, epidermal growth factor...

10.1158/1078-0432.ccr-10-0020 article EN Clinical Cancer Research 2010-10-20

Overexpression of the serine/threonine kinase GLK/MAP4K3 in human lung cancer is associated with poor prognosis and recurrence, however, role GLK recurrence remains unclear. Here, we report that transgenic promotes tumor metastasis cell migration through scaffold protein IQ motif-containing GTPase-activating 1(IQGAP1). mice displayed enhanced distant metastasis. IQGAP1 was identified as a GLK-interacting protein; two proline-rich regions WW domain mediated this interaction. colocalized at...

10.1158/0008-5472.can-19-1402 article EN Cancer Research 2019-08-21

Abstract Purpose: Fas ligand (FasL) −844T/C polymorphism (rs763110) has a demonstrated association with lung cancer risk. FasL −844CC higher expression been suggested to contribute tumor progression via immune escape. However, the impact of on clinical outcome non–small cell (NSCLC) remains be identified. Experimental Design: A total 385 adjacent normal tissues from patients NSCLC were collected determine by PCR-based restriction fragment length polymorphism. mRNA and protein in tumors...

10.1158/1078-0432.ccr-11-0227 article EN Clinical Cancer Research 2011-08-02

Pulmonary sequestration (PS) is a rare congenital lung malformation. In this study, we evaluated the diagnosis and treatment of PS in 31 adult patients at single institution.A retrospective review all 16 years age older with institution between January 1985 2011 was conducted. The following data were analyzed for patients: major symptoms, diagnostic procedures, operative findings, techniques, postoperative complications, outcome.Our study involved patients, 17 male 14 female, an average 32.1...

10.1016/j.jcma.2013.04.002 article EN publisher-specific-oa Journal of the Chinese Medical Association 2013-06-07

// Chung-Ping Hsu 1, 2 , Huai-Chia Chuang 3 Ming-Ching Lee 4 Hsiao-Hui Tsou 5 Li-Wen 1 Ju-Pi Li Tse-Hua Tan 3, 6 Division of Thoracic Surgery, Department Taichung Veterans General Hospital, Taichung, 40705, Taiwan Faculty Medicine, School National Yang-Ming University, Taipei, 11221, Immunology Research Center, Health Institutes, Zhunan, 35053, Institute Clinical Biostatistics and Bioinformatics, Population Sciences, Pathology & Immunology, Baylor College Houston, Texas, 77030, USA...

10.18632/oncotarget.9410 article EN Oncotarget 2016-05-17

Micropapillary (MIP) histologic subtype included in the classification of lung adenocarcinomas (ADCs) is associated with both size- and stage-independent poor prognoses. MIP pattern ADCs, even at small, early stages, correlates high lymphovascular invasion, visceral pleural invasion lymph node metastases. Recently, we reported that patients a component are higher risk locoregional recurrence after limited resection. Identification only possible permanent pathologic sections; preoperative...

10.2217/lmt.14.15 article EN Lung Cancer Management 2014-06-01
Coming Soon ...